Learn more about the Registry
Alternatively, call the registry team toll-free at 1-877-390-2760 (hours of operation 8.30am - 5.00pm EST Monday-Friday)
The Wegovy
Pregnancy Registry
Are you pregnant and diagnosed with either obesity or overweight with at least one weight-related comorbidity?
Have you taken Wegovy® (semaglutide 2.4 mg) or other medications during pregnancy for the treatment of either obesity or overweight with weight-related comorbidities?
Help future pregnant women, doctors, and researchers understand the safety of weight loss medication use during pregnancy.
Are you a healthcare provider who treats pregnant women with a diagnosis of either obesity or overweight with weight-related comorbidities?
Help us learn more about the safety of using Wegovy® (semaglutide 2.4 mg) and other weight loss medications during pregnancy.
About the Wegovy Pregnancy Registry
A pregnancy registry is a study that collects health information from women who take prescription medicines when they are pregnant. Information is also collected on the newborn baby. This information is compared with women who have not taken medicine or have taken other medicines during pregnancy.
The goal of the Wegovy Pregnancy Registry is to help healthcare providers, patients, and researchers better understand the safety of Wegovy® (semaglutide 2.4 mg) and other weight loss medications during pregnancy. Pregnant women in the United States with a diagnosis of either obesity or overweight with at least one weight-related comorbidity may be eligible to participate. The study collects health information on pregnant women and their babies up to 1 year of age from enrolled pregnant women themselves and the healthcare providers involved in their care or the care of their babies.
Would you like to participate?
